EUCRU

Eucrates Biomedical Acquisition Corp. Unit
EUCRU

Delisted

EUCRU was delisted on the 26th of April, 2023.

Back to rankings

14 hedge funds and large institutions have $27.1M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$9.95M
2
-$2.32M
3
-$2.05M
4
GCL
Glazer Capital LLC
New York
-$791K
5
MF
Magnetar Financial
Illinois
-$39.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.29M
2
$4.99M
3
$4.5M
4
$3.97M
5
$2.48M
6
$1.25M
7
$964K
8
$872K
9
$436K
10
$113K
11
$100K
12
$90K
13
$26K
14
$2K
15
–
16
–
17
–
18
–
19
–